Leighanne joined Sofinnova as an Analyst in 2019 focusing on public investments primarily in commercial-stage, global healthcare companies. In 2020 she transitioned to the Private Equity team to focus on biopharmaceutical investments.
Before joining Sofinnova, Leighanne was an investment banking analyst in the Healthcare group at Jefferies. In that role, she focused on M&A, public and private capital raising, licensing deals, and advisory work for biotechnology, pharmaceutical and healthcare retail companies. Before joining Jefferies, Leighanne worked at GE Healthcare as a manufacturing and operations engineer. From 2015 – 2017, Leighanne was a graduate student at Duke University in the laboratory of Dr. Michael Lynch focusing on genetically engineering microbes for therapeutic purposes.
Leighanne received her M.S. and B.S.E in Biomedical Engineering from Duke University and is a Gates Millennium Scholar.